Virus-specific T-cell clonotypes might contribute to drug hypersensitivity reactions through heterologous immunity - 05/08/19
Doi : 10.1016/j.jaci.2019.05.009
Coral-Ann Almeida, BSc, PhD a, b, Paula van Miert, HLO c, Kane O'Driscoll, BSc a, b, Yvonne M. Zoet, HLO c, Abha Chopra, BSc, PhD d, Campbell Witt, BSc, PhD e, Mina John, MBBS d, e, Frans H.J. Claas, PhD c, Lloyd J. D'Orsogna, MBBS, PhD a, b 
a Department of Clinical Immunology and Pathwest, Fiona Stanley Hospital, Perth, Australia
b Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia
c Department of Immunohaematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands
d Institute for Immunology and Infectious Disease, Murdoch University, Perth, Australia
e Department of Clinical Immunology and Pathwest, Royal Perth Hospital, Perth, Australia
| This study is funded by National Health and Medical Research Council (NHMRC), Australian Government grant number APP1034858. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2019
American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Vol 144 - N° 2
P. 608 - août 2019 Retour au numéro
Article précédent
- Combined immunodeficiency in a patient with c-Rel deficiency
- Sarah Beaussant-Cohen, Faris Jaber, Michel J. Massaad, Sabrina Weeks, Jennifer Jones, Mohammed F. Alosaimi, Jacqueline Wallace, Waleed Al-Herz, Raif S. Geha, Janet Chou
- A novel variant in STAT2 presenting with hemophagocytic lymphohistiocytosis
- Mohammed F. Alosaimi, Michelle C. Maciag, Craig D. Platt, Raif S. Geha, Janet Chou, Lisa M. Bartnikas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?